Showing results (41-50 of 605) with videos related to
Sort By:
Pageof 61
Japanese Journal of Clinical Oncology|July 13, 2016
Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancerTetsuya Mizuno, Yasushi Yatabe, Hiroaki Kuroda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patientsHideki Endoh, Yasushi Yatabe, Takayuki Kosaka, et al.The Journal of Molecular Diagnostics : JMD|June 29, 2010
Absence of the caveolin-1 P132L mutation in cancers of the breast and other organsShinya Koike, Yasuhiro Kodera, Akimasa Nakao, et al.Cancer Science|August 27, 2025
Nationwide Real-World Usage of Blood-Based (Liquid) Biomarker Testing in JapanYasushi Yatabe, Ryosuke Watanabe, Yuko Kotera, et al.Pathology, Research and Practice|May 16, 2009
Angioimmunoblastic T-cell lymphoma with autoimmune thrombocytopenia: a report of two casesKuniyuki Oka, Reizo Nagayama, Yasushi Yatabe, et al.International Journal of Clinical Oncology|March 24, 2007
Neuroendocrine tumor metastasis to the thyroid glandHiroko Yamada, Yasuhisa Hasegawa, Tetsuya Mitsudomi, et al.Cancer Research|December 3, 2005
ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine featuresHirotaka Osada, Yoshio Tatematsu, Yasushi Yatabe, et al.Pathology International|January 4, 2007
Pure acinic cell carcinoma of the breast in an 80-year-old Japanese womanChisato Tanahashi, Suguru Yabuki, Noriko Akamine, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinomaTakayuki Kosaka, Yasushi Yatabe, Ryoichi Onozato, et al.Urologia Internationalis|October 3, 2015
Review of Bioptic Gleason Scores by Central Pathologist Modifies the Risk Classification in Prostate CancerNorihito Soga, Yasushi Yatabe, Takumi Kageyama, et al.Pageof 61